On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- 5 Top Tips for Colonoscopy (GI & Endoscopy News)
- Scientists uncover gut signals that may improve early cancer detection (Earth.com)
- The AGA Research Foundation awards $2.9 million in digestive health research funding (EurekAlert!)
- The GI hospitalist: A practice-changing health care opportunity (MDedge)
- Virtual Multidisciplinary GI Care Improves Outcomes, Reduces Costs (Gastroenterology Advisor)
- Validation of the American Society for Gastrointestinal Endoscopy’s Complexity Grading System for Endoscopic Procedures (Clinical and Translational Gastroenterology )
- A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome (Clinical GI & Hepatology)
- Aspirin Unlikely to Cut Colorectal Cancer Incidence (Medscape)
